Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma

Journal Title: Turkish Journal of Hematology - Year 2014, Vol 31, Issue 1

Abstract

Authors and Affiliations

Itır Demiriz, Emre Tekgündüz, Sinem Bozdağ, Fevzi Altuntaş

Keywords

Related Articles

Are university students a favorable target group for blood donation campaigns?

Objective: The aim of this study was to investigate the willingness of university students regarding blood donation and to compare results among residents living in the Kayseri city center. Materials and Methods: Admis...

Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies

Thrombotic microangiopathies (TMAs) are multiple disease entities with different etiopathogeneses, characterized by thrombocytopenia, microangiopathic hemolytic anemia (MAHA) with schistocytosis, variable symptoms includ...

Download PDF file
  • EP ID EP147988
  • DOI 10.4274/Tjh.2013.0180
  • Views 81
  • Downloads 0

How To Cite

Itır Demiriz, Emre Tekgündüz, Sinem Bozdağ, Fevzi Altuntaş (2014). Chronic Myeloid Leukemia as a Secondary Malignancy Following Treatment of Diffuse Large B-Cell Lymphoma. Turkish Journal of Hematology, 31(1), 92-94. https://europub.co.uk/articles/-A-147988